SWI/SNF complexes are required for full activation of the DNA-damage response

Oncotarget

Volumn 6, Issue 2, 2015, Pages 732-745

  Smith Roe, Stephanie L ^a,d   Nakamura, Jun ^b   Holley, Darcy ^a   Chastain, Paul D ^a,c   Rosson, Gary B ^a   Simpson, Dennis A ^a   Ridpath, John R ^a   Kaufman, David G ^a   Kaufmann, William K ^a   Bultman, Scott J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c William Carey University   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

BRG1; BRM; Chemotherapeutics; DNA damage response; Tumor suppression

Indexed keywords

ADENOSINE TRIPHOSPHATASE; APHIDICOLIN; ATR PROTEIN; BRG1 PROTEIN; BRM PROTEIN; CAMPTOTHECIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; ETOPOSIDE; GYRASE INHIBITOR; HISTONE H2AX; PHOSPHOTRANSFERASE; PROTEIN SWI; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SNF; VELIPARIB; DNA HELICASE; NUCLEAR PROTEIN; SMALL INTERFERING RNA; SMARCA2 PROTEIN, HUMAN; SMARCA4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER INHIBITION; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPLEX FORMATION; CONTROLLED STUDY; DEVELOPMENT; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; DRUG CHOICE; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FIBROBLAST; GENE MUTATION; GENE SILENCING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IONIZING RADIATION; MAMMAL; PRIMARY TUMOR; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INDUCTION; TUMOR CELL LINE; CELL SURVIVAL; DEFICIENCY; FEMALE; GENETICS; HELA CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; DNA HELICASES; FEMALE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84921809871     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2715     Document Type: Article

References (72)

1. Euskirchen G, Auerbach R.K, Snyder M. SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functions. The Journal of biological chemistry. 2012; 287:30897-30905.
2. de la Serna I.L, Ohkawa Y, Imbalzano A.N. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nature reviews. Genetics. 2006; 7:461-473.
3. Ho L, Crabtree G.R. Chromatin remodelling during development. Nature. 2010; 463:474-484.
4. Ronan J.L, Wu W, Crabtree G.R. From neural development to cognition: unexpected roles for chromatin. Nature reviews. Genetics. 2013; 14:347-359.
5. Santen G.W, Aten E, Sun Y, Almomani R, Gilissen C, Nielsen M, Kant S.G, Snoeck I.N, Peeters E.A, Hilhorst-Hofstee Y, et al. Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome. Nature genetics. 2012; 44:379-380.
6. Van Houdt J.K, Nowakowska B.A, Sousa S.B, van Schaik B.D, Seuntjens E, Avonce N, Sifrim A, Abdul-Rahman O.A, van den Boogaard M.J, Bottani A, et al. Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome. Nature genetics. 2012; 44:445-449S441.
7. Wilson B.G, Roberts C.W. SWI/SNF nucleosome remodellers and cancer. Nature reviews. Cancer. 2011; 11:481-492.
8. Kadoch C, Hargreaves D.C, Hodges C, Elias L, Ho L, Ranish J, Crabtree G.R. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nature genetics. 2013; 45:592-601.
9. Shain A.H, Pollack J.R. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PloS one. 2013; 8:e55119.
10. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Randazzo F, Metzger D, Chambon P, Crabtree G, et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Molecular cell. 2000; 6:1287-1295.
11. Bultman S.J, Herschkowitz J.I, Godfrey V, Gebuhr T.C, Yaniv M, Perou C.M, Magnuson T. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene. 2008; 27:460-468.
12. Becker T.M, Haferkamp S, Dijkstra M.K, Scurr L.L, Frausto M, Diefenbach E, Scolyer R.A, Reisman D.N, Mann G.J, Kefford R.F, et al. The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Mol Cancer. 2009; 8:4.
13. Hendricks K.B, Shanahan F, Lees E. Role for BRG1 in cell cycle control and tumor suppression. Molecular and cellular biology. 2004; 24:362-376.
14. Kang H, Cui K, Zhao K. BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Molecular and cellular biology. 2004; 24:1188-1199.
15. Kia S.K, Gorski M.M, Giannakopoulos S, Verrijzer C.P. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Molecular and cellular biology. 2008; 28:3457-3464.
16. Oruetxebarria I, Venturini F, Kekarainen T, Houweling A, Zuijderduijn L.M, Mohd-Sarip A, Vries R.G, Hoeben R.C, Verrijzer C.P. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. The Journal of biological chemistry. 2004; 279:3807-3816.
17. Cohen S.M, Chastain P.D 2nd, Rosson G.B, Groh B.S, Weissman B.E, Kaufman D.G, Bultman S.J. BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression. Nucleic acids research. 2010; 38:6906-6919.
18. Petermann E, Helleday T, Caldecott K.W. Claspin promotes normal replication fork rates in human cells. Molecular biology of the cell. 2008; 19:2373-2378.
19. Unsal-Kacmaz K, Chastain P.D, Qu P.P, Minoo P, Cordeiro-Stone M, Sancar A, Kaufmann W.K. The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Molecular and cellular biology. 2007; 27:3131-3142.
20. Lambert S, Carr A.M. Impediments to replication fork movement: stabilisation, reactivation and genome instability. Chromosoma. 2013; 122:33-45.
21. Ciccia A, Elledge S.J. The DNA damage response: making it safe to play with knives. Molecular cell. 2010; 40:179-204.
22. Polo S.E, Jackson S.P. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes & development. 2011; 25:409-433.
23. Branzei D, Foiani M. Maintaining genome stability at the replication fork. Nature reviews. Molecular cell biology. 2010; 11:208-219.
24. Allen C, Ashley A.K, Hromas R, Nickoloff J.A. More forks on the road to replication stress recovery. Journal of molecular cell biology. 2011; 3:4-12.
25. Horikawa I, Okamoto A, Yokota J, Oshimura M. Genetic heterogeneity of chromosome 11 associated with tumorigenicity in HeLa D98-OR cells. Cancer genetics and cytogenetics. 1995; 85:97-100.
26. Jones S, Wang T.L, Shih Ie M, Mao T.L, Nakayama K, Roden R, Glas R, Slamon D, Diaz L.A Jr, Vogelstein B, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010; 330:228-231.
27. Kuo K.T, Liang C.W, Hsiao C.H, Lin C.H, Chen C.A, Sheu B.C, Lin M.C. Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma. Mod Pathol. 2006; 19:1570-1577.
28. Serber D.W, Rogala A, Makarem M, Rosson G.B, Simin K, Godfrey V, Van Dyke T, Eaves C.J, Bultman S.J. The BRG1 Chromatin Remodeler Protects Against Ovarian Cysts, Uterine Tumors, and Mammary Tumors in a Lineage-Specific Manner. PloS one. 2012; 7:e31346.
29. Wiegand K.C, Shah S.P, Al-Agha O.M, Zhao Y, Tse K, Zeng T, Senz J, McConechy M.K, Anglesio M.S, Kalloger S.E, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. The New England journal of medicine. 2010; 363:1532-1543.
30. Bajpai R, Chen D.A, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, Chang C.P, Zhao Y, Swigut T, Wysocka J. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature. 2010; 463:958-962.
31. Hang C.T, Yang J, Han P, Cheng H.L, Shang C, Ashley E, Zhou B, Chang C.P. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature. 2010; 466:62-67.
32. Underhill C, Toulmonde M, Bonnefoi H. A review of PARP inhibitors: from bench to bedside. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2011; 22:268-279.
33. Farmer H, McCabe N, Lord C.J, Tutt A.N, Johnson D.A, Richardson T.B, Santarosa M, Dillon K.J, Hickson I, Knights C, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005; 434:917-921.
34. Fong P.C, Boss D.S, Yap T.A, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor M.J, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. The New England journal of medicine. 2009; 361:123-134.
35. Bochar D.A, Wang L, Beniya H, Kinev A, Xue Y, Lane W.S, Wang W, Kashanchi F, Shiekhattar R. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell. 2000; 102:257-265.
36. Harte M.T, O'Brien G.J, Ryan N.M, Gorski J.J, Savage K.I, Crawford N.T, Mullan P.B, Harkin D.P. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer research. 2010; 70:2538-2547.
37. Hill D.A, de la Serna I.L, Veal T.M, Imbalzano A.N. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2. J Cell Biochem. 2004; 91:987-998.
38. Adachi N, So S, Koyama H. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage. The Journal of biological chemistry. 2004; 279:37343-37348.
39. Nakamura J, Asakura S, Hester S.D, de Murcia G, Caldecott K.W, Swenberg J.A. Quantitation of intracellular NAD(P)H can monitor an imbalance of DNA single strand break repair in base excision repair deficient cells in real time. Nucleic acids research. 2003; 31:e104.
40. Smith J, Tho L.M, Xu N, Gillespie D.A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Advances in cancer research. 2010; 108:73-112.
41. Lee H.S, Park J.H, Kim S.J, Kwon S.J, Kwon J. A cooperative activation loop among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair. The EMBO journal. 2010; 29:1434-1445.
42. Park J.H, Park E.J, Lee H.S, Kim S.J, Hur S.K, Imbalzano A.N, Kwon J. Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. The EMBO journal. 2006; 25:3986-3997.
43. Dykhuizen E.C, Hargreaves D.C, Miller E.L, Cui K, Korshunov A, Kool M, Pfister S, Cho Y.J, Zhao K, Crabtree G.R. BAF complexes facilitate decatenation of DNA by topoisomerase IIalpha. Nature. 2013; 497:624-627.
44. Boyer J.C, Kaufmann W.K, Brylawski B.P, Cordeiro-Stone M. Defective postreplication repair in xeroderma pigmentosum variant fibroblasts. Cancer research. 1990; 50:2593-2598.
45. Simpson D.A, Livanos E, Heffernan T.P, Kaufmann W.K. Telomerase expression is sufficient for chromosomal integrity in cells lacking p53 dependent G1 checkpoint function. Journal of carcinogenesis. 2005; 4:18.
46. Reyes J.C, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). The EMBO journal. 1998; 17:6979-6991.
47. Holik A.Z, Krzystyniak J, Young M, Richardson K, Jarde T, Chambon P, Shorning B.Y, Clarke A.R. Brg1 is Required for Stem Cell Maintenance in the Murine Intestinal Epithelium in a Tissue-Specific Manner. Stem Cells. 2013; 31:2457-2466.
48. Smith-Roe S.L, Bultman S.J. Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. Mammalian genome: official journal of the International Mammalian Genome Society. 2013; 24:21-29.
49. Willis M.S, Homeister J.W, Rosson G.B, Annayev Y, Holley D, Holly S.P, Madden V.J, Godfrey V, Parise L.V, Bultman S.J. Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart. Circulation research. 2012; 111:e111-122.
50. Matsuoka S, Ballif B.A, Smogorzewska A, McDonald E.R 3rd, Hurov K.E, Luo J, Bakalarski C.E, Zhao Z, Solimini N, Lerenthal Y, et al. ATM, and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007; 316:1160-1166.
51. Kwon S.J, Park J.H, Park E.J, Lee S.A, Lee H.S, Kang S.W, Kwon J. ATM-mediated phosphorylation of the chromatin remodeling enzyme BRG1 modulates DNA double-strand break repair. Oncogene. 2014; Jan 13. doi: 10.1038/onc.2013.556.
52. Chai B, Huang J, Cairns B.R, Laurent B.C. Distinct roles for the RSC and Swi/Snf ATP-dependent chromatin remodelers in DNA double-strand break repair. Genes & development. 2005; 19:1656-1661.
53. Gong F, Fahy D, Liu H, Wang W, Smerdon M.J. Role of the mammalian SWI/SNF chromatin remodeling complex in the cellular response to UV damage. Cell Cycle. 2008; 7:1067-1074.
54. Gong F, Fahy D, Smerdon M.J. Rad4-Rad23 interaction with SWI/SNF links ATP-dependent chromatin remodeling with nucleotide excision repair. Nature structural & molecular biology. 2006; 13:902-907.
55. Hara R, Sancar A. The SWI/SNF chromatin-remodeling factor stimulates repair by human excision nuclease in the mononucleosome core particle. Molecular and cellular biology. 2002; 22:6779-6787.
56. Hara R, Sancar A. Effect of damage type on stimulation of human excision nuclease by SWI/SNF chromatin remodeling factor. Molecular and cellular biology. 2003; 23:4121-4125.
57. Kent N.A, Chambers A.L, Downs J.A. Dual chromatin remodeling roles for RSC during DNA double strand break induction and repair at the yeast MAT locus. The Journal of biological chemistry. 2007; 282:27693-27701.
58. Ray A, Mir S.N, Wani G, Zhao Q, Battu A, Zhu Q, Wang Q.E, Wani A.A. Human SNF5/INI1, a component of the human SWI/SNF chromatin remodeling complex, promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation. Molecular and cellular biology. 2009; 29:6206-6219.
59. Shim E.Y, Ma J.L, Oum J.H, Yanez Y, Lee S.E. The yeast chromatin remodeler RSC complex facilitates end joining repair of DNA double-strand breaks. Molecular and cellular biology. 2005; 25:3934-3944.
60. Zhang L, Zhang Q, Jones K, Patel M, Gong F. The chromatin remodeling factor BRG1 stimulates nucleotide excision repair by facilitating recruitment of XPC to sites of DNA damage. Cell Cycle. 2009; 8:3953-3959.
61. Zhao Q, Wang Q.E, Ray A, Wani G, Han C, Milum K, Wani A.A. Modulation of nucleotide excision repair by mammalian SWI/SNF chromatin-remodeling complex. The Journal of biological chemistry. 2009; 284:30424-30432.
62. Kothandapani A, Gopalakrishnan K, Kahali B, Reisman D, Patrick S.M. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Experimental cell research. 2012; 318:1973-1986.
63. Bourgo R.J, Siddiqui H, Fox S, Solomon D, Sansam C.G, Yaniv M, Muchardt C, Metzger D, Chambon P, Roberts C.W, et al. SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity. Molecular biology of the cell. 2009; 20:3192-3199.
64. Imbalzano K.M, Cohet N, Wu Q, Underwood J.M, Imbalzano A.N, Nickerson J.A. Nuclear shape changes are induced by knockdown of the SWI/SNF ATPase BRG1 and are independent of cytoskeletal connections. PloS one. 2013; 8:e55628.
65. Imbalzano A.N, Imbalzano K.M, Nickerson J.A. BRG1, a SWI/SNF chromatin remodeling enzyme ATPase, is required for maintenance of nuclear shape and integrity. Communicative & integrative biology. 2013; 6:e25153.
66. Klochendler-Yeivin A, Picarsky E, Yaniv M. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex. Molecular and cellular biology. 2006; 26:2661-2674.
67. Janssen A, van der Burg M, Szuhai K, Kops G.J, Medema R.H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science. 2011; 333:1895-1898.
68. Jeon Y, Ko E, Lee K.Y, Ko M.J, Park S.Y, Kang J, Jeon C.H, Lee H, Hwang D.S. TopBP1 deficiency causes an early embryonic lethality and induces cellular senescence in primary cells. The Journal of biological chemistry. 2011; 286:5414-5422.
69. Kim J.E, McAvoy S.A, Smith D.I, Chen J. Human TopBP1 ensures genome integrity during normal S phase. Molecular and cellular biology. 2005; 25:10907-10915.
70. Ridpath J.R, Nakamura A, Tano K, Luke A.M, Sonoda E, Arakawa H, Buerstedde J.M, Gillespie D.A, Sale J.E, Yamazoe M, et al. Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer research. 2007; 67:11117-11122.
71. Ridpath J.R, Takeda S, Swenberg J.A, Nakamura J. Convenient, multi-well plate-based DNA damage response analysis using DT40 mutants is applicable to a high-throughput genotoxicity assay with characterization of modes of action. Environmental and molecular mutagenesis. 2011; 52:153-160.
72. Smith-Roe S.L, Patel S.S, Zhou Y, Simpson D.A, Rao S, Ibrahim J.G, Cordeiro-Stone M, Kaufmann W.K. Separation of intra-S checkpoint protein contributions to DNA replication fork protection and genomic stability in normal human fibroblasts. Cell Cycle. 2013; 12:332-345.